Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways
Anthracycline anticancer drugs (e.g., doxorubicin or daunorubicin) can induce chronic cardiotoxicity and heart failure (HF), both of which are believed to be based on oxidative injury and mitochondrial damage. In this study, molecular and functional changes induced by chronic anthracycline treatment...
Gespeichert in:
Veröffentlicht in: | The Journal of pharmacology and experimental therapeutics 2012-11, Vol.343 (2), p.468-478 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 478 |
---|---|
container_issue | 2 |
container_start_page | 468 |
container_title | The Journal of pharmacology and experimental therapeutics |
container_volume | 343 |
creator | Jirkovsky, Eduard Popelová, Olga Kriváková-Stanková, Pavla Vávrová, Anna Hroch, Milos Hasková, Pavlína Brcáková-Dolezelová, Eva Micuda, Stanislav Adamcová, Michaela Simůnek, Tomás Cervinková, Zuzana Gersl, Vladimír Sterba, Martin |
description | Anthracycline anticancer drugs (e.g., doxorubicin or daunorubicin) can induce chronic cardiotoxicity and heart failure (HF), both of which are believed to be based on oxidative injury and mitochondrial damage. In this study, molecular and functional changes induced by chronic anthracycline treatment with progression into HF in post-treatment follow-up were analyzed with special emphasis on nuclear factor erythroid 2-related factor 2 (Nrf2) and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α) pathways. Chronic cardiotoxicity was induced in rabbits with daunorubicin (3 mg/kg, weekly for 10 weeks), and the animals were followed for another 10 weeks. Echocardiography revealed a significant drop in left ventricular (LV) systolic function during the treatment with marked progression to LV dilation and congestive HF in the follow-up. Although daunorubicin-induced LV lipoperoxidation was found, it was only loosely associated with cardiac performance. Furthermore, although LV oxidized glutathione content was increased, the oxidized-to-reduced glutathione ratio itself remained unchanged. Neither Nrf2, the master regulator of antioxidant response, nor the majority of its target genes showed up-regulation in the study. However, down-regulation of manganese superoxide dismutase and NAD(P)H dehydrogenase [quinone] 1 were observed together with heme oxygenase 1 up-regulation. Although marked perturbations in mitochondrial functions were found, no induction of PGC1α-controlled mitochondrial biogenesis pathway was revealed. Instead, especially in the post-treatment period, an impaired regulation of this pathway was observed along with down-regulation of the expression of mitochondrial genes. These results imply that global oxidative stress need not be a factor responsible for the development of anthracycline-induced HF, whereas suppression of mitochondrial biogenesis might be involved. |
doi_str_mv | 10.1124/jpet.112.198358 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1124_jpet_112_198358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22915767</sourcerecordid><originalsourceid>FETCH-LOGICAL-c297t-908896fb1911764f2335417fbb77d5d1ba58af21b87595fccd4f5228b0234acc3</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0EgvJYs0P-gbR-xHmwQxUvCYkNrCNnbBNXqV3Zjkq-iN8kocBq7mjunMVB6JqSJaUsX212Os1pSeuKi-oILahgNCOU8GO0IISxjItCnKHzGDeE0Dwv-Ck6Y6ymoizKBfpad8E7C1i61AUJI_TWaQwyKOuT_7Rg03iLt77XMPQyTD2FzeAgWe9kP62yH6ONeG9Th42HIWLvsBug11PbSEg-YB3Gie6twiwLupdJq78T-yFubfLQeaeCnaCt9R_a6Rm7k6nbyzFeohMj-6ivfucFen-4f1s_ZS-vj8_ru5cMWF2mrCZVVRempTWlZZEbxrnIaWnatiyVULSVopKG0bYqRS0MgMqNYKxqCeO5BOAXaHXgQvAxBm2aXbBbGcaGkmZW3szK59QclE8fN4eP3dButfrv_znm36RYgj0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Jirkovsky, Eduard ; Popelová, Olga ; Kriváková-Stanková, Pavla ; Vávrová, Anna ; Hroch, Milos ; Hasková, Pavlína ; Brcáková-Dolezelová, Eva ; Micuda, Stanislav ; Adamcová, Michaela ; Simůnek, Tomás ; Cervinková, Zuzana ; Gersl, Vladimír ; Sterba, Martin</creator><creatorcontrib>Jirkovsky, Eduard ; Popelová, Olga ; Kriváková-Stanková, Pavla ; Vávrová, Anna ; Hroch, Milos ; Hasková, Pavlína ; Brcáková-Dolezelová, Eva ; Micuda, Stanislav ; Adamcová, Michaela ; Simůnek, Tomás ; Cervinková, Zuzana ; Gersl, Vladimír ; Sterba, Martin</creatorcontrib><description>Anthracycline anticancer drugs (e.g., doxorubicin or daunorubicin) can induce chronic cardiotoxicity and heart failure (HF), both of which are believed to be based on oxidative injury and mitochondrial damage. In this study, molecular and functional changes induced by chronic anthracycline treatment with progression into HF in post-treatment follow-up were analyzed with special emphasis on nuclear factor erythroid 2-related factor 2 (Nrf2) and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α) pathways. Chronic cardiotoxicity was induced in rabbits with daunorubicin (3 mg/kg, weekly for 10 weeks), and the animals were followed for another 10 weeks. Echocardiography revealed a significant drop in left ventricular (LV) systolic function during the treatment with marked progression to LV dilation and congestive HF in the follow-up. Although daunorubicin-induced LV lipoperoxidation was found, it was only loosely associated with cardiac performance. Furthermore, although LV oxidized glutathione content was increased, the oxidized-to-reduced glutathione ratio itself remained unchanged. Neither Nrf2, the master regulator of antioxidant response, nor the majority of its target genes showed up-regulation in the study. However, down-regulation of manganese superoxide dismutase and NAD(P)H dehydrogenase [quinone] 1 were observed together with heme oxygenase 1 up-regulation. Although marked perturbations in mitochondrial functions were found, no induction of PGC1α-controlled mitochondrial biogenesis pathway was revealed. Instead, especially in the post-treatment period, an impaired regulation of this pathway was observed along with down-regulation of the expression of mitochondrial genes. These results imply that global oxidative stress need not be a factor responsible for the development of anthracycline-induced HF, whereas suppression of mitochondrial biogenesis might be involved.</description><identifier>ISSN: 0022-3565</identifier><identifier>EISSN: 1521-0103</identifier><identifier>DOI: 10.1124/jpet.112.198358</identifier><identifier>PMID: 22915767</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Anthracyclines - toxicity ; Antibiotics, Antineoplastic - toxicity ; Cell Nucleus - drug effects ; Cell Nucleus - metabolism ; Daunorubicin - pharmacology ; Echocardiography ; Glutathione - metabolism ; Heart Diseases - chemically induced ; Heart Diseases - metabolism ; Heart Function Tests ; Heart Ventricles - drug effects ; Heart Ventricles - metabolism ; Lipid Peroxidation - drug effects ; Male ; Mitochondria, Heart - drug effects ; Mitochondria, Heart - metabolism ; Myocardium - pathology ; NF-E2-Related Factor 2 - biosynthesis ; Oxidative Stress - drug effects ; Rabbits ; Real-Time Polymerase Chain Reaction ; Survival ; Transcription Factors - metabolism ; Troponin T - metabolism</subject><ispartof>The Journal of pharmacology and experimental therapeutics, 2012-11, Vol.343 (2), p.468-478</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c297t-908896fb1911764f2335417fbb77d5d1ba58af21b87595fccd4f5228b0234acc3</citedby><cites>FETCH-LOGICAL-c297t-908896fb1911764f2335417fbb77d5d1ba58af21b87595fccd4f5228b0234acc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22915767$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jirkovsky, Eduard</creatorcontrib><creatorcontrib>Popelová, Olga</creatorcontrib><creatorcontrib>Kriváková-Stanková, Pavla</creatorcontrib><creatorcontrib>Vávrová, Anna</creatorcontrib><creatorcontrib>Hroch, Milos</creatorcontrib><creatorcontrib>Hasková, Pavlína</creatorcontrib><creatorcontrib>Brcáková-Dolezelová, Eva</creatorcontrib><creatorcontrib>Micuda, Stanislav</creatorcontrib><creatorcontrib>Adamcová, Michaela</creatorcontrib><creatorcontrib>Simůnek, Tomás</creatorcontrib><creatorcontrib>Cervinková, Zuzana</creatorcontrib><creatorcontrib>Gersl, Vladimír</creatorcontrib><creatorcontrib>Sterba, Martin</creatorcontrib><title>Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways</title><title>The Journal of pharmacology and experimental therapeutics</title><addtitle>J Pharmacol Exp Ther</addtitle><description>Anthracycline anticancer drugs (e.g., doxorubicin or daunorubicin) can induce chronic cardiotoxicity and heart failure (HF), both of which are believed to be based on oxidative injury and mitochondrial damage. In this study, molecular and functional changes induced by chronic anthracycline treatment with progression into HF in post-treatment follow-up were analyzed with special emphasis on nuclear factor erythroid 2-related factor 2 (Nrf2) and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α) pathways. Chronic cardiotoxicity was induced in rabbits with daunorubicin (3 mg/kg, weekly for 10 weeks), and the animals were followed for another 10 weeks. Echocardiography revealed a significant drop in left ventricular (LV) systolic function during the treatment with marked progression to LV dilation and congestive HF in the follow-up. Although daunorubicin-induced LV lipoperoxidation was found, it was only loosely associated with cardiac performance. Furthermore, although LV oxidized glutathione content was increased, the oxidized-to-reduced glutathione ratio itself remained unchanged. Neither Nrf2, the master regulator of antioxidant response, nor the majority of its target genes showed up-regulation in the study. However, down-regulation of manganese superoxide dismutase and NAD(P)H dehydrogenase [quinone] 1 were observed together with heme oxygenase 1 up-regulation. Although marked perturbations in mitochondrial functions were found, no induction of PGC1α-controlled mitochondrial biogenesis pathway was revealed. Instead, especially in the post-treatment period, an impaired regulation of this pathway was observed along with down-regulation of the expression of mitochondrial genes. These results imply that global oxidative stress need not be a factor responsible for the development of anthracycline-induced HF, whereas suppression of mitochondrial biogenesis might be involved.</description><subject>Animals</subject><subject>Anthracyclines - toxicity</subject><subject>Antibiotics, Antineoplastic - toxicity</subject><subject>Cell Nucleus - drug effects</subject><subject>Cell Nucleus - metabolism</subject><subject>Daunorubicin - pharmacology</subject><subject>Echocardiography</subject><subject>Glutathione - metabolism</subject><subject>Heart Diseases - chemically induced</subject><subject>Heart Diseases - metabolism</subject><subject>Heart Function Tests</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - metabolism</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Male</subject><subject>Mitochondria, Heart - drug effects</subject><subject>Mitochondria, Heart - metabolism</subject><subject>Myocardium - pathology</subject><subject>NF-E2-Related Factor 2 - biosynthesis</subject><subject>Oxidative Stress - drug effects</subject><subject>Rabbits</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>Survival</subject><subject>Transcription Factors - metabolism</subject><subject>Troponin T - metabolism</subject><issn>0022-3565</issn><issn>1521-0103</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMtOwzAQRS0EgvJYs0P-gbR-xHmwQxUvCYkNrCNnbBNXqV3Zjkq-iN8kocBq7mjunMVB6JqSJaUsX212Os1pSeuKi-oILahgNCOU8GO0IISxjItCnKHzGDeE0Dwv-Ck6Y6ymoizKBfpad8E7C1i61AUJI_TWaQwyKOuT_7Rg03iLt77XMPQyTD2FzeAgWe9kP62yH6ONeG9Th42HIWLvsBug11PbSEg-YB3Gie6twiwLupdJq78T-yFubfLQeaeCnaCt9R_a6Rm7k6nbyzFeohMj-6ivfucFen-4f1s_ZS-vj8_ru5cMWF2mrCZVVRempTWlZZEbxrnIaWnatiyVULSVopKG0bYqRS0MgMqNYKxqCeO5BOAXaHXgQvAxBm2aXbBbGcaGkmZW3szK59QclE8fN4eP3dButfrv_znm36RYgj0</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>Jirkovsky, Eduard</creator><creator>Popelová, Olga</creator><creator>Kriváková-Stanková, Pavla</creator><creator>Vávrová, Anna</creator><creator>Hroch, Milos</creator><creator>Hasková, Pavlína</creator><creator>Brcáková-Dolezelová, Eva</creator><creator>Micuda, Stanislav</creator><creator>Adamcová, Michaela</creator><creator>Simůnek, Tomás</creator><creator>Cervinková, Zuzana</creator><creator>Gersl, Vladimír</creator><creator>Sterba, Martin</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20121101</creationdate><title>Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways</title><author>Jirkovsky, Eduard ; Popelová, Olga ; Kriváková-Stanková, Pavla ; Vávrová, Anna ; Hroch, Milos ; Hasková, Pavlína ; Brcáková-Dolezelová, Eva ; Micuda, Stanislav ; Adamcová, Michaela ; Simůnek, Tomás ; Cervinková, Zuzana ; Gersl, Vladimír ; Sterba, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c297t-908896fb1911764f2335417fbb77d5d1ba58af21b87595fccd4f5228b0234acc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Anthracyclines - toxicity</topic><topic>Antibiotics, Antineoplastic - toxicity</topic><topic>Cell Nucleus - drug effects</topic><topic>Cell Nucleus - metabolism</topic><topic>Daunorubicin - pharmacology</topic><topic>Echocardiography</topic><topic>Glutathione - metabolism</topic><topic>Heart Diseases - chemically induced</topic><topic>Heart Diseases - metabolism</topic><topic>Heart Function Tests</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - metabolism</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Male</topic><topic>Mitochondria, Heart - drug effects</topic><topic>Mitochondria, Heart - metabolism</topic><topic>Myocardium - pathology</topic><topic>NF-E2-Related Factor 2 - biosynthesis</topic><topic>Oxidative Stress - drug effects</topic><topic>Rabbits</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>Survival</topic><topic>Transcription Factors - metabolism</topic><topic>Troponin T - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jirkovsky, Eduard</creatorcontrib><creatorcontrib>Popelová, Olga</creatorcontrib><creatorcontrib>Kriváková-Stanková, Pavla</creatorcontrib><creatorcontrib>Vávrová, Anna</creatorcontrib><creatorcontrib>Hroch, Milos</creatorcontrib><creatorcontrib>Hasková, Pavlína</creatorcontrib><creatorcontrib>Brcáková-Dolezelová, Eva</creatorcontrib><creatorcontrib>Micuda, Stanislav</creatorcontrib><creatorcontrib>Adamcová, Michaela</creatorcontrib><creatorcontrib>Simůnek, Tomás</creatorcontrib><creatorcontrib>Cervinková, Zuzana</creatorcontrib><creatorcontrib>Gersl, Vladimír</creatorcontrib><creatorcontrib>Sterba, Martin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jirkovsky, Eduard</au><au>Popelová, Olga</au><au>Kriváková-Stanková, Pavla</au><au>Vávrová, Anna</au><au>Hroch, Milos</au><au>Hasková, Pavlína</au><au>Brcáková-Dolezelová, Eva</au><au>Micuda, Stanislav</au><au>Adamcová, Michaela</au><au>Simůnek, Tomás</au><au>Cervinková, Zuzana</au><au>Gersl, Vladimír</au><au>Sterba, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways</atitle><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle><addtitle>J Pharmacol Exp Ther</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>343</volume><issue>2</issue><spage>468</spage><epage>478</epage><pages>468-478</pages><issn>0022-3565</issn><eissn>1521-0103</eissn><abstract>Anthracycline anticancer drugs (e.g., doxorubicin or daunorubicin) can induce chronic cardiotoxicity and heart failure (HF), both of which are believed to be based on oxidative injury and mitochondrial damage. In this study, molecular and functional changes induced by chronic anthracycline treatment with progression into HF in post-treatment follow-up were analyzed with special emphasis on nuclear factor erythroid 2-related factor 2 (Nrf2) and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α) pathways. Chronic cardiotoxicity was induced in rabbits with daunorubicin (3 mg/kg, weekly for 10 weeks), and the animals were followed for another 10 weeks. Echocardiography revealed a significant drop in left ventricular (LV) systolic function during the treatment with marked progression to LV dilation and congestive HF in the follow-up. Although daunorubicin-induced LV lipoperoxidation was found, it was only loosely associated with cardiac performance. Furthermore, although LV oxidized glutathione content was increased, the oxidized-to-reduced glutathione ratio itself remained unchanged. Neither Nrf2, the master regulator of antioxidant response, nor the majority of its target genes showed up-regulation in the study. However, down-regulation of manganese superoxide dismutase and NAD(P)H dehydrogenase [quinone] 1 were observed together with heme oxygenase 1 up-regulation. Although marked perturbations in mitochondrial functions were found, no induction of PGC1α-controlled mitochondrial biogenesis pathway was revealed. Instead, especially in the post-treatment period, an impaired regulation of this pathway was observed along with down-regulation of the expression of mitochondrial genes. These results imply that global oxidative stress need not be a factor responsible for the development of anthracycline-induced HF, whereas suppression of mitochondrial biogenesis might be involved.</abstract><cop>United States</cop><pmid>22915767</pmid><doi>10.1124/jpet.112.198358</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3565 |
ispartof | The Journal of pharmacology and experimental therapeutics, 2012-11, Vol.343 (2), p.468-478 |
issn | 0022-3565 1521-0103 |
language | eng |
recordid | cdi_crossref_primary_10_1124_jpet_112_198358 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Animals Anthracyclines - toxicity Antibiotics, Antineoplastic - toxicity Cell Nucleus - drug effects Cell Nucleus - metabolism Daunorubicin - pharmacology Echocardiography Glutathione - metabolism Heart Diseases - chemically induced Heart Diseases - metabolism Heart Function Tests Heart Ventricles - drug effects Heart Ventricles - metabolism Lipid Peroxidation - drug effects Male Mitochondria, Heart - drug effects Mitochondria, Heart - metabolism Myocardium - pathology NF-E2-Related Factor 2 - biosynthesis Oxidative Stress - drug effects Rabbits Real-Time Polymerase Chain Reaction Survival Transcription Factors - metabolism Troponin T - metabolism |
title | Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A15%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20anthracycline%20cardiotoxicity:%20molecular%20and%20functional%20analysis%20with%20focus%20on%20nuclear%20factor%20erythroid%202-related%20factor%202%20and%20mitochondrial%20biogenesis%20pathways&rft.jtitle=The%20Journal%20of%20pharmacology%20and%20experimental%20therapeutics&rft.au=Jirkovsky,%20Eduard&rft.date=2012-11-01&rft.volume=343&rft.issue=2&rft.spage=468&rft.epage=478&rft.pages=468-478&rft.issn=0022-3565&rft.eissn=1521-0103&rft_id=info:doi/10.1124/jpet.112.198358&rft_dat=%3Cpubmed_cross%3E22915767%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22915767&rfr_iscdi=true |